Hrdinka et al., 2016 - Google Patents
CYLD limits Lys63-and Met1-linked ubiquitin at receptor complexes to regulate innate immune signalingHrdinka et al., 2016
View HTML- Document ID
- 11862003922326002592
- Author
- Hrdinka M
- Fiil B
- Zucca M
- Leske D
- Bagola K
- Yabal M
- Elliott P
- Damgaard R
- Komander D
- Jost P
- Gyrd-Hansen M
- Publication year
- Publication venue
- Cell reports
External Links
Snippet
Innate immune signaling relies on the deposition of non-degradative polyubiquitin at receptor-signaling complexes, but how these ubiquitin modifications are regulated by deubiquitinases remains incompletely understood. Met1-linked ubiquitin (Met1-Ub) is …
- 108010086291 Deubiquitinating Enzyme CYLD 0 title abstract description 129
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hrdinka et al. | CYLD limits Lys63-and Met1-linked ubiquitin at receptor complexes to regulate innate immune signaling | |
Tan et al. | Posttranscriptional regulation of de novo lipogenesis by glucose-induced O-GlcNAcylation | |
Wang et al. | Aneuploid senescent cells activate NF‐κB to promote their immune clearance by NK cells | |
Dick et al. | Caspase 3 cleavage of Pax7 inhibits self-renewal of satellite cells | |
Zhang et al. | OTUD1 negatively regulates type I IFN induction by disrupting noncanonical ubiquitination of IRF3 | |
Yamamoto et al. | Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6α and XBP1 | |
Johmura et al. | SCFFbxo22-KDM4A targets methylated p53 for degradation and regulates senescence | |
Singleton et al. | OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation | |
Johansson et al. | SCF-FBXO31 E3 ligase targets DNA replication factor Cdt1 for proteolysis in the G2 phase of cell cycle to prevent re-replication | |
Tang et al. | Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor 2 | |
Murina et al. | FANCD2 and CtIP cooperate to repair DNA interstrand crosslinks | |
Shimokawa et al. | RNA editing of the GLI1 transcription factor modulates the output of Hedgehog signaling | |
Chen et al. | MicroRNA-195 promotes apoptosis in mouse podocytes via enhanced caspase activity driven by BCL2 insufficiency | |
Mochizuki et al. | Combinatorial CRISPR/Cas9 approach to elucidate a far-upstream enhancer complex for tissue-specific Sox9 expression | |
Smyth et al. | A 14‐3‐3 mode‐1 binding motif initiates gap junction internalization during acute cardiac ischemia | |
Kurisu et al. | MDG1/ERdj4, an ER‐resident DnaJ family member, suppresses cell death induced by ER stress | |
Hartkamp et al. | The Wilms' tumor suppressor protein WT1 is processed by the serine protease HtrA2/Omi | |
Suzuki et al. | Nuclear TDP-43 causes neuronal toxicity by escaping from the inhibitory regulation by hnRNPs | |
Qing et al. | USP7 regulates the stability and function of HLTF through deubiquitination | |
Tripathi et al. | Abrogation of FBW7α-dependent p53 degradation enhances p53’s function as a tumor suppressor | |
Renaudin et al. | BRCA2 deficiency reveals that oxidative stress impairs RNaseH1 function to cripple mitochondrial DNA maintenance | |
Shen et al. | RanBP2/Nup358 enhances miRNA activity by sumoylating Argonautes | |
Nayak et al. | Regulation of SETD7 methyltransferase by SENP3 is crucial for sarcomere organization and cachexia | |
Tsai et al. | RNA helicase DDX3 maintains lipid homeostasis through upregulation of the microsomal triglyceride transfer protein by interacting with HNF4 and SHP | |
Tang et al. | FOXK1 participates in DNA damage response by controlling 53BP1 function |